Eli Lilly and Company
893 S Delaware St
Indianapolis
Indiana
46285
United States
About Eli Lilly and Company
Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.
Karina found her fit at Lilly through our summer internship program. She is now hoping to inspire more Latinx students to make changes in the STEM field just as her mentor did for her. Visit careers.lilly.com/LRL to find open roles in Lilly’s research labs. #WeAreLilly
3415 articles about Eli Lilly and Company
-
Eli Lilly and Company Release: Phase III Data Show Investigational Compound Empagliflozin Plus Insulin Significantly Reduced Hba1c in Adults With Type 2 Diabetes
6/24/2013
-
Eli Lilly and Company Relase: Phase III Data Show Significant Reduction in Blood Glucose With Investigational Compound Empagliflozin Added to Metformin or Metformin Plus Sulfonylurea in Adults With Type 2 Diabetes
6/24/2013
-
Boehringer Ingelheim Corporation and Eli Lilly and Company Release: Real Time Assessm Results of New Meta-Analysis Regarding CV Events in Linagliptin Phase 3 Trials Presented at American Diabetes Association
6/24/2013
-
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company's Tradjenta and Jentadueto Labeling to Reflect Pancreatitis Risk
6/21/2013
-
Eli Lilly and Company Fights Scam Artists Over Use of Its Name
6/20/2013
-
FDA Probes Deaths of Two Patients on Eli Lilly and Company Schizophrenia Drug
6/19/2013
-
Eli Lilly and Company Declares Third-Quarter 2013 Dividend
6/19/2013
-
Covance Inc. Hosts Governor Pence, PhRMA and Eli Lilly and Company to Highlight Economic and Health Impact of Clinical Trial Research in Indiana
6/19/2013
-
Novo Nordisk A/S Drops as New Eli Lilly and Company Drug Threatens Victoza
6/18/2013
-
Eli Lilly and Company Diabetes, Kris Freeman Kick off Summer With 9th Annual Diabetes Summer Camp Tour
6/18/2013
-
What Eli Lilly and Company's Cut Alzheimer's Drug Means for Merck & Co., Inc.
6/17/2013
-
Transition Therapeutics Inc. to Get $7 Million as Eli Lilly and Company to Assume Rights to TT-401
6/17/2013
-
Safety Fears Force Eli Lilly and Company to Halt Alzheimer's Trial
6/17/2013
-
Boehringer Ingelheim Corporation and Eli Lilly and Company Statement on the American Diabetes Association Request for Independent Review of Incretin-Based Therapies
6/14/2013
-
Eli Lilly and Company, Incyte Corporation Arthritis Pill Effective in Mid-Stage Study
6/13/2013
-
Eli Lilly and Company to Highlight Late-Stage Pipeline Molecules at the 73rd American Diabetes Association Scientific Sessions
6/11/2013
-
Boehringer Ingelheim GmbH and Eli Lilly and Company Alliance to Feature 34 Presentations in Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions®
6/11/2013
-
Eli Lilly and Company Says Superiority Study of Alimta for Lung Cancer Fails to Meet Goals
6/4/2013
-
Eli Lilly and Company Statement on Indiana Biosciences Research Institute
5/31/2013
-
Indiana Businesses Such as Eli Lilly and Company, Dow AgroSciences LLC, Cook Medical Others Join to Form First Industry-Led Biosciences Research Institute, Aims to Attract 100 R&D Scientists
5/30/2013